Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for proximal humerus fracture repair (TERAFRAP)
NCT02091492Phase 3Withdrawn
- Sponsor
- Medical University of Vienna
- Start
- Jun 2014
- Primary completion
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of teriparatide in Humerus fracture, sponsored by Medical University of Vienna. Planned start Jun 2014; status: withdrawn.
02
Drugs
teriparatide
03
Conditions
Humerus fracture
Beyond the preview
Go deeper on NCT02091492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091492.